Mafoprazine mesylate

N/A

Report date: 2024/01/25 09:18:09
NME

Base Information

Drug NameMafoprazine mesylate
Drug Alias NameIK-640
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsAdrenergic receptor alpha-1 antagonistsAdrenergic receptors alpha-2 antagonists
TargetsDopamine D2 receptorAdrenergic receptors alpha-1Adrenergic receptors alpha-2
Therapy Area/IndicationsSedationSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma CorpSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo DainipponMitsubishi Tanabe Pharma
Active IndicationsN/A
Inactive IndicationsSedationSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A